Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risdiplam in infants with type 1 spinal muscular atrophy (Phase 2)
jRCT2080223835Phase 2Completed
- Sponsor
- Chugai Pharmaceutical Co., Ltd.
- Start
- Mar 2018
- Modality
- Small Molecules
01
Overview
Phase 2, open-label, single-arm trial of risdiplam in spinal muscular atrophy type 1, sponsored by Chugai Pharmaceutical Co., Ltd. Started Mar 2018; status: completed.
02
Drugs
risdiplam
03
Conditions
spinal muscular atrophy type 1
Beyond the preview
Go deeper on jRCT2080223835.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223835.